AMD Genetics: Methods and Analyses for Association, Progression, and Prediction.


Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2021
Historique:
entrez: 13 4 2021
pubmed: 14 4 2021
medline: 16 4 2021
Statut: ppublish

Résumé

Age-related macular degeneration (AMD) is a multifactorial neurodegenerative disease, which is a leading cause of vision loss among the elderly in the developed countries. As one of the most successful examples of genome-wide association study (GWAS), a large number of genetic studies have been conducted to explore the genetic basis for AMD and its progression, of which over 30 loci were identified and confirmed. In this chapter, we review the recent development and findings of GWAS for AMD risk and progression. Then, we present emerging methods and models for predicting AMD development or its progression using large-scale genetic data. Finally, we discuss a set of novel statistical and analytical methods that were recently developed to tackle the challenges such as analyzing bilateral correlated eye-level outcomes that are subject to censoring with high-dimensional genetic data. Future directions for analytical studies of AMD genetics are also proposed.

Identifiants

pubmed: 33848002
doi: 10.1007/978-3-030-66014-7_7
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

191-200

Références

Age-Related Eye Disease Study Research Group (1999) The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. Control Clin Trials 20:573–600
doi: 10.1016/S0197-2456(99)00031-8
Jager RD, Mieler WF, Miller JW (2008) Age-related macular degeneration. N Engl J Med 358:2606–2617
pubmed: 18550876 doi: 10.1056/NEJMra0801537
Swaroop A, Chew EY, Rickman CB, Abecasis GR (2009) Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 10:19–43
pubmed: 19405847 pmcid: 3469316 doi: 10.1146/annurev.genom.9.081307.164350
Seddon JM, Ajani UA, Mitchell BD (1997) Familial aggregation of age-related maculopathy. Am J Ophthalmol 123:199–206
pubmed: 9186125 doi: 10.1016/S0002-9394(14)71036-0
Seddon JM, Cote J, Page WF, Aggen SH, Neale MC (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123:321–327
pubmed: 15767473 doi: 10.1001/archopht.123.3.321
Fisher SA et al (2005) Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet 14:2257–2264
pubmed: 15987700 doi: 10.1093/hmg/ddi230
Klein RJ et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385–389
pubmed: 1512523 pmcid: 1512523 doi: 10.1126/science.1109557
Gold B et al (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38:458–462
pubmed: 16518403 pmcid: 2921703 doi: 10.1038/ng1750
Fagerness JA et al (2009) Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet 17:100–104
pubmed: 18685559 doi: 10.1038/ejhg.2008.140 pmcid: 18685559
Yates JR et al (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357:553–561
pubmed: 17634448 doi: 10.1056/NEJMoa072618
Yang Z et al (2006) A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314:992–993
pubmed: 17053109 doi: 10.1126/science.1133811
Jakobsdottir J et al (2005) Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77:389–407
pubmed: 16080115 pmcid: 1226205 doi: 10.1086/444437
Fritsche LG et al (2013) Seven new loci associated with age-related macular degeneration. Nat Genet 45:433–439
pubmed: 23455636 doi: 10.1038/ng.2578
Yu Y et al (2011) Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet 20:3699–3709
pubmed: 21665990 pmcid: 3159552 doi: 10.1093/hmg/ddr270
Fritsche LG et al (2016) A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet 48:134–143
pubmed: 26691988 doi: 10.1038/ng.3448
Zhan X et al (2013) Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat Genet 45:1375–1379
pubmed: 24036949 pmcid: 3812337 doi: 10.1038/ng.2758
Kondo N, Bessho H, Honda S, Negi A (2011) Complement factor H Y402H variant and risk of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 118:339–344
pubmed: 20869121 doi: 10.1016/j.ophtha.2010.06.040
Restrepo NA et al (2014) Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study. Invest Ophthalmol Vis Sci 55:6839–6850
pubmed: 25205864 pmcid: 4214207 doi: 10.1167/iovs.14-14246
Spencer KL, Glenn K, Brown-Gentry K, Haines JL, Crawford DC (2012) Population differences in genetic risk for age-related macular degeneration and implications for genetic testing. Arch Ophthalmol 130:116–117
pubmed: 22232482 pmcid: 3326353 doi: 10.1001/archopthalmol.2011.1370
DeAngelis MM et al (2017) Genetics of age-related macular degeneration (AMD). Hum Mol Genet 26:R246
pubmed: 28977452 pmcid: 6262235 doi: 10.1093/hmg/ddx343
AREDS2 Research Group et al (2012) The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology 119:2282–2289
doi: 10.1016/j.ophtha.2012.05.027
Age-Related Eye Disease Study 2 Research Group (2013) Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 309:2005–2015
doi: 10.1001/jama.2013.4997
Seddon JM et al (2007) Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 297:1793–1800
pubmed: 17456821 doi: 10.1001/jama.297.16.1793
Seddon JM, Reynolds R, Yu Y, Rosner B (2014) Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration. PLoS One 9:e87047
pubmed: 24498017 pmcid: 3909074 doi: 10.1371/journal.pone.0087047
Perlee LT et al (2013) Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy. Ophthalmology 120:1880–1892
pubmed: 23523162 pmcid: 3695024 doi: 10.1016/j.ophtha.2013.02.007
Farwick A, Wellmann J, Stoll M, Pauleikhoff D, Hense HW (2010) Susceptibility genes and progression in age-related maculopathy: a study of single eyes. Invest Ophthalmol Vis Sci 51:731–736
pubmed: 19797206 doi: 10.1167/iovs.09-3953
Yu Y, Reynolds R, Rosner B, Daly MJ, Seddon JM (2012) Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Invest Ophthalmol Vis Sci 53:1548–1556
pubmed: 22247473 pmcid: 3339916 doi: 10.1167/iovs.11-8657
Gangnon RE et al (2014) Misclassification can explain most apparent regression of age-related macular degeneration: results from multistate models with misclassification. Invest Ophthalmol Vis Sci 55:1780–1786
pubmed: 24550369 pmcid: 3968926 doi: 10.1167/iovs.13-12375
Sardell RJ et al (2016) Progression rate from intermediate to advanced age-related macular degeneration is correlated with the number of risk alleles at the CFH locus. Invest Ophthalmol Vis Sci 57:6107–6115
pubmed: 27832277 pmcid: 5104418 doi: 10.1167/iovs.16-19519
Ding Y et al (2017) Bivariate analysis of age-related macular degeneration progression using genetic risk scores. Genetics 206:119–133
pubmed: 28341650 pmcid: 5419464 doi: 10.1534/genetics.116.196998
Klein R, Klein BE, Myers CE (2011) Risk assessment models for late age-related macular degeneration. Arch Ophthalmol 129:1605–1606
pubmed: 22159681 doi: 10.1001/archophthalmol.2011.372
Yan Q et al (2018) Genome-wide analysis of disease progression in age-related macular degeneration. Hum Mol Genet 27:929–940
pubmed: 29346644 pmcid: 6059197 doi: 10.1093/hmg/ddy002
Sun T, Liu Y, Cook RJ, Chen W, Ding Y (2018) Copula-based score test for bivariate time-to-event data, with application to a genetic study of AMD progression. Lifetime Data Anal
Sun T, Ding Y (2019) Copula-based semiparametric regression method for bivariate data under general interval censoring. Biostatistics
Seddon JM et al (2009) Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci 50:2044–2053
pubmed: 19117936 doi: 10.1167/iovs.08-3064
Seddon JM, Reynolds R, Yu Y, Daly MJ, Rosner B (2011) Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology 118:2203–2211
pubmed: 21959373 pmcid: 4097877 doi: 10.1016/j.ophtha.2011.04.029
Seddon JM (2013) Genetic and environmental underpinnings to age-related ocular diseases. Invest Ophthalmol Vis Sci 54:ORSF28–ORSF30
pubmed: 24335064 pmcid: 3864375 doi: 10.1167/iovs.13-13234
Abramoff MD et al (2016) Improved automated detection of diabetic retinopathy on a publicly available dataset through integration of deep learning. Invest Ophthalmol Vis Sci 57:5200–5206
pubmed: 27701631 doi: 10.1167/iovs.16-19964
Gulshan V et al (2016) Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA 316:2402–2410
pubmed: 27898976 doi: 10.1001/jama.2016.17216
Kermany DS et al (2018) Identifying medical diagnoses and treatable diseases by image-based deep learning. Cell 172:1122–1131.e9
doi: 10.1016/j.cell.2018.02.010
Devalla SK et al (2018) A deep learning approach to digitally stain optical coherence tomography images of the optic nerve head. Invest Ophthalmol Vis Sci 59:63–74
pubmed: 29313052 doi: 10.1167/iovs.17-22617
Grassmann F et al (2018) A deep learning algorithm for prediction of age-related eye disease study severity scale for age-related macular degeneration from color fundus photography. Ophthalmology 125:1410–1420
pubmed: 29653860 doi: 10.1016/j.ophtha.2018.02.037
Burlina PM et al (2017) Automated grading of age-related macular degeneration from color fundus images using deep convolutional neural networks. JAMA Ophthalmol 135:1170–1176
pubmed: 28973096 pmcid: 28973096 doi: 10.1001/jamaophthalmol.2017.3782
Poplin R et al (2018) Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Nat Biomed Eng 2:158–164
pubmed: 31015713 doi: 10.1038/s41551-018-0195-0
Peng Y et al (2019) DeepSeeNet: a deep learning model for automated classification of patient-based age-related macular degeneration severity from color fundus photographs. Ophthalmology 126:565–575
pubmed: 30471319 doi: 10.1016/j.ophtha.2018.11.015
Yan Q et al (2020) Deep-learning-based prediction of late age-related macular degeneration progression. Nat Mach Intell 2:141–150
pubmed: 32285025 pmcid: 7153739 doi: 10.1038/s42256-020-0154-9
Restrepo NA et al (2015) Mitochondrial variation and the risk of age-related macular degeneration across diverse populations. Pac Symp Biocomput 2015:243–254
Riazi-Esfahani M, Kuppermann BD, Kenney MC (2017) The role of mitochondria in AMD: current knowledge and future applications. J Ophthalmic Vis Res 12:424–428
pubmed: 29090054 pmcid: 5644411 doi: 10.4103/jovr.jovr_182_17
Udar N et al (2009) Mitochondrial DNA haplogroups associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 50:2966–2974
pubmed: 19151382 doi: 10.1167/iovs.08-2646
Askou AL, Alsing S, Holmgaard A, Bek T, Corydon TJ (2018) Dissecting microRNA dysregulation in age-related macular degeneration: new targets for eye gene therapy. Acta Ophthalmol 96:9–23
pubmed: 28271607 doi: 10.1111/aos.13407
Elshelmani H, Rani S (2017) Exosomal MicroRNA discovery in age-related macular degeneration. Methods Mol Biol 1509:93–113
pubmed: 27826921 doi: 10.1007/978-1-4939-6524-3_10
Desmettre TJ (2018) Epigenetics in age-related macular degeneration (AMD). J Fr Ophtalmol 41:e407–e415
pubmed: 30458925 doi: 10.1016/j.jfo.2018.09.001
Gemenetzi M, Lotery AJ (2014) The role of epigenetics in age-related macular degeneration. Eye (Lond) 28:1407–1417
doi: 10.1038/eye.2014.225
Liu MM, Chan CC, Tuo J (2012) Genetic mechanisms and age-related macular degeneration: common variants, rare variants, copy number variations, epigenetics, and mitochondrial genetics. Hum Genomics 6:13
pubmed: 23244519 pmcid: 3500238 doi: 10.1186/1479-7364-6-13
Ratnapriya R et al (2019) Retinal transcriptome and eQTL analyses identify genes associated with age-related macular degeneration. Nat Genet
Wei Y, Liu Y, Sun T, Chen W, Ding Y (2019) Gene-based association analysis for bivariate time-to-event data through functional regression with copula models. Biometrics. https://doi.org/10.1111/biom.13165
Russakoff DB, Lamin A, Oakley JD, Dubis AM, Sivaprasad S (2019) Deep learning for prediction of AMD progression: a pilot study. Invest Ophthalmol Vis Sci 60:712–722
pubmed: 30786275 doi: 10.1167/iovs.18-25325
Wei Y, Hsu JC, Chen W, Chew EY,Ding Y (2020) A simultaneous inference procedure to identify subgroups from RCTs with survival outcomes: application to analysis of AMD progression studies. arXiv preprint arXiv:2003.10528
Ding Y, Kong S, Kang S, Chen W (2018) A semiparametric imputation approach for regression with censored covariate with application to an AMD progression study. Stat Med 37:3293–3308
pubmed: 29845616 doi: 10.1002/sim.7816
Handa JT et al (2019) A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration. Nat Commun 10:3347
pubmed: 31350409 pmcid: 6659646 doi: 10.1038/s41467-019-11262-1
Peng Y et al (2018) DeepSeeNet: a deep learning model for automated classification of patient-based age-related macular degeneration severity from color fundus photographs. Ophthalmology. https://doi.org/10.1016/j.ophtha.2018.11.015

Auteurs

Qi Yan (Q)

Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY, USA.

Ying Ding (Y)

Department of Biostatistics, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.

Daniel E Weeks (DE)

Department of Biostatistics, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.

Wei Chen (W)

Division of Pulmonary Medicine, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, USA. wec47@pitt.edu.
Department of Biostatistics, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. wec47@pitt.edu.
Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. wec47@pitt.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH